Skip to main content
Past event1st EditionSynthetic BiologyBiopharma

2026 Synthetic Biology IP Forum (1st Edition · Shanghai)

27 March 2026Shanghai, China · Grand Mercure Shanghai HongqiaoSYNBIO-2026

About the Conference

About the Conference

The first Synthetic Biology IP Forum was held on 27 March 2026 at the Grand Mercure Shanghai Hongqiao. It was jointly hosted by Zhiwen Consulting and Zhichan Huicui, with guidance and support from the Shanghai Synthetic Biology Industry Association, and sponsored by Beijing Linktec IP Agency, Suzhou Sinofaith Zhishu Technology, TAYA IP and Beijing Guozhuan IP.

Under the theme "IP Driving Synthetic Biology Manufacturing", the forum attracted more than 150 experts, scholars and corporate delegates from across China. Attendees came from Beijing, Tianjin, Guangdong, Shandong and the Yangtze River Delta, with synthetic biology companies accounting for over 75% of participants, heads of leading domestic law firms around 20%, and a further 5% of overseas lawyers from Korea, India and Germany.

As the first professional forum dedicated to IP in synthetic biology, the event built a bridge between industry and intellectual property. Keynotes covered the state of the IP protection system for synthetic biology, making trade secret protection measurable, recent judicial developments in technical secret cases, patent strategy in plant synthetic biology, PCT filing practice and the Biobucks model. Two panel discussions addressed risk control and portfolio strategy for innovators, alongside a welcome dinner and exhibitor showcase.

On Site

Moments

Why Attend

Highlights

  • 01

    150+ attendees, with synthetic biology companies making up over 75%

  • 02

    The first professional forum dedicated to IP in synthetic biology

  • 03

    6 keynote reports + 2 panel discussions + welcome dinner

  • 04

    Coverage from measurable trade secrets and technical secret litigation to plant synthetic biology, PCT practice and the Biobucks model

Topics & Agenda

Key Topics

Institutions and protection systems

03
  • The IP protection system for synthetic biology: current state, gaps and recommendations
  • From policy on the wall to data on the board — making trade secret protection measurable
  • Recent judicial developments in technical secret cases

Patent strategy and filing practice

02
  • Plant synthetic biology and patent portfolio strategy
  • International patent filing strategy and PCT practice in synthetic biology

Value capture and risk control

03
  • The logic and limits of the Biobucks model in biomanufacturing
  • IP risk control for synthetic biology innovators
  • IP portfolio strategy for synthetic biology innovators

Overview of Speakers

Speakers

  • Wang Cong

    Wang Cong

    Tianjin National Synthetic Biology Technology Innovation Center

    Senior IP Specialist

  • Tao Weiwei

    Tao Weiwei

    Sinofaith Group

    Head of Trade Secret Practice, General Manager of Suzhou Sinofaith

  • Song Jian

    Song Jian

    Jiangsu High People's Court

    Former Member of the Adjudication Committee and Chief Judge of the IP Tribunal

  • Liu Hongchen

    Liu Hongchen

    Beijing Qihe Biotechnology

    Head of IP

  • Lu Shaonan

    Lu Shaonan

    Beijing YinZheng Biotechnology

    Director of IP and Legal Affairs

  • Hu Qinming

    Hu Qinming

    Moon (Guangzhou) Biotech

    Head of IP

  • Zhang Dan

    Beijing Linktec IP Agency

    Partner (Panel Chair)

  • Chen Yuejun

    Beijing Sino-Creativity IP Agency

    Manager of the Domestic Biochemistry Department (Panel Chair)

Panel Discussions

Panel: IP risk control for synthetic biology innovators

Panel: IP risk control for synthetic biology innovators

Host: Zhang Dan (Partner, Beijing Linktec IP Agency)

Panellists:

  • Zhang Qi (IP Director, GenScript Biotech)
  • Liu Xin (IP Director, Shanghai Cathay Biotech)
  • Hu Qinming (Head of IP, Moon (Guangzhou) Biotech)
  • Li Caihui (Partner, Jingsheng Capital)
Panel: IP portfolio strategy for synthetic biology innovators

Panel: IP portfolio strategy for synthetic biology innovators

Host: Chen Yuejun (Manager, Domestic Biochemistry Department, Beijing Sino-Creativity IP Agency)

Panellists:

  • Lu Shaonan (Director of IP and Legal Affairs, Beijing YinZheng Biotechnology)
  • Liu Hongchen (Head of IP, Beijing Qihe Biotechnology)
  • Wang Cong (Senior IP Specialist, Tianjin National Synthetic Biology Technology Innovation Center)

Hosted By

Organisers

  • Zhiwen Consulting
  • Zhichan Huicui

Supported By

Supporters

  • Shanghai Synthetic Biology Industry AssociationShanghai Synthetic Biology Industry Association

In Partnership With

Partners

  • Beijing Linktec IP Agency
  • Suzhou Sinofaith Zhishu Technology
  • TAYA IP
  • Beijing Guozhuan IP

SYNBIO-2026 · see you at the next edition

For the full agenda or registration details, get in touch with the organising committee — we usually reply within one business day.

Full Report

Read the full post-event report

Originally published on our WeChat account, including the full session recap and photo gallery.